- Home
- EDIT vs MAMO Comparison
EDIT vs MAMO Comparison
Compare EDIT & MAMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- MAMO
- Stock Information
- Founded
- EDIT 2013
- MAMO 2008
- Country
- EDIT United States
- MAMO United States
- Employees
- EDIT N/A
- MAMO N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- MAMO
- Sector
- EDIT Health Care
- MAMO
- Exchange
- EDIT Nasdaq
- MAMO NYSE
- Market Cap
- EDIT 99.9M
- MAMO 102.6M
- IPO Year
- EDIT 2016
- MAMO 2024
- Fundamental
- Price
- EDIT $1.21
- MAMO $2.77
- Analyst Decision
- EDIT Buy
- MAMO
- Analyst Count
- EDIT 14
- MAMO 0
- Target Price
- EDIT $8.08
- MAMO N/A
- AVG Volume (30 Days)
- EDIT 2.7M
- MAMO 55.6K
- Earning Date
- EDIT 02-26-2025
- MAMO 11-15-2024
- Dividend Yield
- EDIT N/A
- MAMO N/A
- EPS Growth
- EDIT N/A
- MAMO N/A
- EPS
- EDIT N/A
- MAMO 0.18
- Revenue
- EDIT $61,759,000.00
- MAMO $130,710,373.00
- Revenue This Year
- EDIT N/A
- MAMO N/A
- Revenue Next Year
- EDIT N/A
- MAMO N/A
- P/E Ratio
- EDIT N/A
- MAMO $15.14
- Revenue Growth
- EDIT 150.95
- MAMO 30.14
- 52 Week Low
- EDIT $1.12
- MAMO $2.42
- 52 Week High
- EDIT $11.58
- MAMO $4.66
- Technical
- Relative Strength Index (RSI)
- EDIT 34.86
- MAMO N/A
- Support Level
- EDIT $1.15
- MAMO N/A
- Resistance Level
- EDIT $1.27
- MAMO N/A
- Average True Range (ATR)
- EDIT 0.10
- MAMO 0.00
- MACD
- EDIT 0.04
- MAMO 0.00
- Stochastic Oscillator
- EDIT 21.11
- MAMO 0.00
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About MAMO MASSIMO GROUP
Massimo Group is engaged in the mid-tier band the (Mid-Tier Band) of the Powersports Vehicles and Boats Industry. It manufacture, import and distribute a diversified portfolio of products divided into two main lines: a motor sports brand consisting of utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), motorcycles, scooters, golf carts and a juvenile line from go karts to balance bikes; and a motor boat line consisting of pontoon and tritoon boats (Pontoon Boats).